| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| AMOT | LATS1 | ENSBTAP00000063307 | ENSBTAP00000020062 | Angiomotin. | Large tumor suppressor kinase 1. | 0.984 |
| AMOT | LATS2 | ENSBTAP00000063307 | ENSBTAP00000019161 | Angiomotin. | Large tumor suppressor kinase 2. | 0.965 |
| AMOT | TEAD1 | ENSBTAP00000063307 | ENSBTAP00000062884 | Angiomotin. | TEA domain transcription factor 1. | 0.570 |
| AMOT | TEAD4 | ENSBTAP00000063307 | ENSBTAP00000063710 | Angiomotin. | TEA domain transcription factor 4. | 0.650 |
| AMOT | YAP1 | ENSBTAP00000063307 | ENSBTAP00000006112 | Angiomotin. | Yes associated protein 1. | 0.993 |
| AMOT | YWHAB | ENSBTAP00000063307 | ENSBTAP00000022411 | Angiomotin. | 14-3-3 protein beta/alpha, N-terminally processed; Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis. Blocks the nuclear translocation of the phosphorylated form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on cyclin D1 expression resulting in blockage of neuronal apoptosis elicited by [...] | 0.627 |
| LATS1 | AMOT | ENSBTAP00000020062 | ENSBTAP00000063307 | Large tumor suppressor kinase 1. | Angiomotin. | 0.984 |
| LATS1 | LATS2 | ENSBTAP00000020062 | ENSBTAP00000019161 | Large tumor suppressor kinase 1. | Large tumor suppressor kinase 2. | 0.997 |
| LATS1 | TEAD1 | ENSBTAP00000020062 | ENSBTAP00000062884 | Large tumor suppressor kinase 1. | TEA domain transcription factor 1. | 0.875 |
| LATS1 | TEAD2 | ENSBTAP00000020062 | ENSBTAP00000021752 | Large tumor suppressor kinase 1. | TEA domain transcription factor 2. | 0.784 |
| LATS1 | TEAD3 | ENSBTAP00000020062 | ENSBTAP00000025965 | Large tumor suppressor kinase 1. | Transcriptional enhancer factor TEF-5; Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. | 0.758 |
| LATS1 | TEAD4 | ENSBTAP00000020062 | ENSBTAP00000063710 | Large tumor suppressor kinase 1. | TEA domain transcription factor 4. | 0.825 |
| LATS1 | YAP1 | ENSBTAP00000020062 | ENSBTAP00000006112 | Large tumor suppressor kinase 1. | Yes associated protein 1. | 0.999 |
| LATS1 | YWHAB | ENSBTAP00000020062 | ENSBTAP00000022411 | Large tumor suppressor kinase 1. | 14-3-3 protein beta/alpha, N-terminally processed; Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. Negative regulator of osteogenesis. Blocks the nuclear translocation of the phosphorylated form (by AKT1) of SRPK2 and antagonizes its stimulatory effect on cyclin D1 expression resulting in blockage of neuronal apoptosis elicited by [...] | 0.588 |
| LATS2 | AMOT | ENSBTAP00000019161 | ENSBTAP00000063307 | Large tumor suppressor kinase 2. | Angiomotin. | 0.965 |
| LATS2 | LATS1 | ENSBTAP00000019161 | ENSBTAP00000020062 | Large tumor suppressor kinase 2. | Large tumor suppressor kinase 1. | 0.997 |
| LATS2 | SMAD7 | ENSBTAP00000019161 | ENSBTAP00000043987 | Large tumor suppressor kinase 2. | Mothers against decapentaplegic homolog. | 0.430 |
| LATS2 | TEAD1 | ENSBTAP00000019161 | ENSBTAP00000062884 | Large tumor suppressor kinase 2. | TEA domain transcription factor 1. | 0.822 |
| LATS2 | TEAD2 | ENSBTAP00000019161 | ENSBTAP00000021752 | Large tumor suppressor kinase 2. | TEA domain transcription factor 2. | 0.732 |
| LATS2 | TEAD3 | ENSBTAP00000019161 | ENSBTAP00000025965 | Large tumor suppressor kinase 2. | Transcriptional enhancer factor TEF-5; Transcription factor which plays a key role in the Hippo signaling pathway, a pathway involved in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. | 0.714 |
